Edition:
India

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

7,300JPY
21 Jun 2018
Change (% chg)

-- (--)
Prev Close
¥7,300
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
136,994
52-wk High
¥7,350
52-wk Low
¥2,761

Latest Key Developments (Source: Significant Developments)

JR-131, long-acting erythropoiesis-stimulating agent, demonstrates equivalence in phase III study
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Kissei Pharmaceutical Co Ltd <4547.T>:Says it and JCR Pharmaceuticals Co Ltd <<<4552.T>>> jointly announced positive results of the phase III study for JR-131, a proposed biosimilar to darbepoetin alfa, a long-acting erythropoiesis-stimulating agent for the treatment of renal anemia .In the Phase III study initiated in August 2016, JR-131 demonstrated equivalence in efficacy and safety compared with darbepoetin.Accordingly, in a primary endpoint of efficacy, the equivalence was verified for variations in hemoglobin concentration and the similarity with regard to the safety profile was confirmed .  Full Article

Medipal Holdings signs contract to set up JV JCR USA with JCR Pharmaceuticals
Tuesday, 19 Dec 2017 

Dec 19(Reuters) - Medipal Holdings Corp <7459.T>:Says it signed a contract to set up a JV JCR USA Inc with JCR Pharmaceuticals Co Ltd <<<4552.T>>>.Says the JV will be established in January 2018.Says the company and JCR Pharmaceuticals will hold a 35 percent stake and a 65 percent stake in the JV respectively .  Full Article

JCR Pharmaceuticals to initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says it will initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo.  Full Article

NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:* Says it and NanoCarrier Co., Ltd <4571.T> conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines .* Under this agreement, Nanocarrier and JCR will integrate the unique technologies and knowledge of both companies, and aim to develop an innovative drug effectively delivered to the brain .  Full Article

BRIEF-JCR Pharmaceuticals to set up investigational new drug production center with investment of 3 bln yen

* Says it will set up an investigational new drug production center with investment of about 3 billion yen from March 2019